Cargando…

GC/MS Profiling and Ex Vivo Antibacterial Activity of Salvadora persica (Siwak) against Enterococcus faecalis as Intracanal Medicament

INTRODUCTION: Salvadora persica L. (S. persica, Siwak) has been used for many centuries as oral hygiene tools, particularly in Saudi Arabia. This study aimed to assess the effectiveness of S. persica petroleum ether extract (SPE) as an intracanal bactericidal for endodontic treatment against Enteroc...

Descripción completa

Detalles Bibliográficos
Autores principales: Ayoub, Nahla, Badr, Nadia, Al-Ghamdi, Saeed S, Alzahrani, Arwa, Alsulaimani, Rahaf, Nassar, Afnan, Qadi, Rawabi, Afifi, Ibtesam K., Swilam, Noha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8723863/
https://www.ncbi.nlm.nih.gov/pubmed/34987597
http://dx.doi.org/10.1155/2021/6333867
_version_ 1784625812039794688
author Ayoub, Nahla
Badr, Nadia
Al-Ghamdi, Saeed S
Alzahrani, Arwa
Alsulaimani, Rahaf
Nassar, Afnan
Qadi, Rawabi
Afifi, Ibtesam K.
Swilam, Noha
author_facet Ayoub, Nahla
Badr, Nadia
Al-Ghamdi, Saeed S
Alzahrani, Arwa
Alsulaimani, Rahaf
Nassar, Afnan
Qadi, Rawabi
Afifi, Ibtesam K.
Swilam, Noha
author_sort Ayoub, Nahla
collection PubMed
description INTRODUCTION: Salvadora persica L. (S. persica, Siwak) has been used for many centuries as oral hygiene tools, particularly in Saudi Arabia. This study aimed to assess the effectiveness of S. persica petroleum ether extract (SPE) as an intracanal bactericidal for endodontic treatment against Enterococcus faecalis. Calcium hydroxide Ca(OH)(2) gold standard intracanal medicament was used for comparison. METHODS: The gas chromatography mass spectrometry (GC/MS) analysis was carried out to identify the components of SPE. First, the consistency of SPE was accomplished according to ANSI/ADA specification no 57. Forty-five single-rooted mandibular premolars were infected with that of E. faecalis suspension. Colony-forming units (CFU) were counted before the medicaments' application (CFU-1) and after seven days of their applications (CFU-2). Group I: SPE, Group II: positive control Ca(OH)(2), and Group III: saline solution negative control. The microdilution method was applied to determine minimal inhibitory concentration (MIC) and minimal bactericidal concentration (MBC) of SPE. RESULTS: Thirty-two compounds were identified (89.09%), with main components of benzyl isothiocyanate (BITC) (33.32%) and steroids (34%). CFU before and after using SPE and Ca(OH)(2) recorded a statistically significant reduction in bacterial count (P=0.006) and (P=0.01), respectively. There was an insignificant difference between CFU after using SPE and Ca(OH)(2) (P=0.210). On the contrary, comparing both medicaments with the negative control saline group resulted in significant differences, (P=0.001) and (P=0.007), respectively. Moreover, the equality of minimum bactericidal concentration (MBC) and minimum inhibitory concentration (MIC) of SPE is recorded. CONCLUSION: This finding could be referred to the high content of bactericidal BITC in synergism with other antimicrobial components, representing 70.71% of SPE. Thus, SPE is a good candidate as an intracanal medicament, which warrants further investigation.
format Online
Article
Text
id pubmed-8723863
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-87238632022-01-04 GC/MS Profiling and Ex Vivo Antibacterial Activity of Salvadora persica (Siwak) against Enterococcus faecalis as Intracanal Medicament Ayoub, Nahla Badr, Nadia Al-Ghamdi, Saeed S Alzahrani, Arwa Alsulaimani, Rahaf Nassar, Afnan Qadi, Rawabi Afifi, Ibtesam K. Swilam, Noha Evid Based Complement Alternat Med Research Article INTRODUCTION: Salvadora persica L. (S. persica, Siwak) has been used for many centuries as oral hygiene tools, particularly in Saudi Arabia. This study aimed to assess the effectiveness of S. persica petroleum ether extract (SPE) as an intracanal bactericidal for endodontic treatment against Enterococcus faecalis. Calcium hydroxide Ca(OH)(2) gold standard intracanal medicament was used for comparison. METHODS: The gas chromatography mass spectrometry (GC/MS) analysis was carried out to identify the components of SPE. First, the consistency of SPE was accomplished according to ANSI/ADA specification no 57. Forty-five single-rooted mandibular premolars were infected with that of E. faecalis suspension. Colony-forming units (CFU) were counted before the medicaments' application (CFU-1) and after seven days of their applications (CFU-2). Group I: SPE, Group II: positive control Ca(OH)(2), and Group III: saline solution negative control. The microdilution method was applied to determine minimal inhibitory concentration (MIC) and minimal bactericidal concentration (MBC) of SPE. RESULTS: Thirty-two compounds were identified (89.09%), with main components of benzyl isothiocyanate (BITC) (33.32%) and steroids (34%). CFU before and after using SPE and Ca(OH)(2) recorded a statistically significant reduction in bacterial count (P=0.006) and (P=0.01), respectively. There was an insignificant difference between CFU after using SPE and Ca(OH)(2) (P=0.210). On the contrary, comparing both medicaments with the negative control saline group resulted in significant differences, (P=0.001) and (P=0.007), respectively. Moreover, the equality of minimum bactericidal concentration (MBC) and minimum inhibitory concentration (MIC) of SPE is recorded. CONCLUSION: This finding could be referred to the high content of bactericidal BITC in synergism with other antimicrobial components, representing 70.71% of SPE. Thus, SPE is a good candidate as an intracanal medicament, which warrants further investigation. Hindawi 2021-12-27 /pmc/articles/PMC8723863/ /pubmed/34987597 http://dx.doi.org/10.1155/2021/6333867 Text en Copyright © 2021 Nahla Ayoub et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Ayoub, Nahla
Badr, Nadia
Al-Ghamdi, Saeed S
Alzahrani, Arwa
Alsulaimani, Rahaf
Nassar, Afnan
Qadi, Rawabi
Afifi, Ibtesam K.
Swilam, Noha
GC/MS Profiling and Ex Vivo Antibacterial Activity of Salvadora persica (Siwak) against Enterococcus faecalis as Intracanal Medicament
title GC/MS Profiling and Ex Vivo Antibacterial Activity of Salvadora persica (Siwak) against Enterococcus faecalis as Intracanal Medicament
title_full GC/MS Profiling and Ex Vivo Antibacterial Activity of Salvadora persica (Siwak) against Enterococcus faecalis as Intracanal Medicament
title_fullStr GC/MS Profiling and Ex Vivo Antibacterial Activity of Salvadora persica (Siwak) against Enterococcus faecalis as Intracanal Medicament
title_full_unstemmed GC/MS Profiling and Ex Vivo Antibacterial Activity of Salvadora persica (Siwak) against Enterococcus faecalis as Intracanal Medicament
title_short GC/MS Profiling and Ex Vivo Antibacterial Activity of Salvadora persica (Siwak) against Enterococcus faecalis as Intracanal Medicament
title_sort gc/ms profiling and ex vivo antibacterial activity of salvadora persica (siwak) against enterococcus faecalis as intracanal medicament
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8723863/
https://www.ncbi.nlm.nih.gov/pubmed/34987597
http://dx.doi.org/10.1155/2021/6333867
work_keys_str_mv AT ayoubnahla gcmsprofilingandexvivoantibacterialactivityofsalvadorapersicasiwakagainstenterococcusfaecalisasintracanalmedicament
AT badrnadia gcmsprofilingandexvivoantibacterialactivityofsalvadorapersicasiwakagainstenterococcusfaecalisasintracanalmedicament
AT alghamdisaeeds gcmsprofilingandexvivoantibacterialactivityofsalvadorapersicasiwakagainstenterococcusfaecalisasintracanalmedicament
AT alzahraniarwa gcmsprofilingandexvivoantibacterialactivityofsalvadorapersicasiwakagainstenterococcusfaecalisasintracanalmedicament
AT alsulaimanirahaf gcmsprofilingandexvivoantibacterialactivityofsalvadorapersicasiwakagainstenterococcusfaecalisasintracanalmedicament
AT nassarafnan gcmsprofilingandexvivoantibacterialactivityofsalvadorapersicasiwakagainstenterococcusfaecalisasintracanalmedicament
AT qadirawabi gcmsprofilingandexvivoantibacterialactivityofsalvadorapersicasiwakagainstenterococcusfaecalisasintracanalmedicament
AT afifiibtesamk gcmsprofilingandexvivoantibacterialactivityofsalvadorapersicasiwakagainstenterococcusfaecalisasintracanalmedicament
AT swilamnoha gcmsprofilingandexvivoantibacterialactivityofsalvadorapersicasiwakagainstenterococcusfaecalisasintracanalmedicament